1 - 25 of
28
results
for author:"Rong L."
in Literature Citations
| p53-dependent translational control of senescence and transformation via 4E-BPs. Petroulakis E., Parsyan A., Dowling R.J., LeBacquer O., Martineau Y., Bidinosti M., Larsson O., Alain T., Rong L., Mamane Y. et al. Cancer Cell 16:439-446(2009) · Mapped (8) |
| Insulin-like growth factor II mRNA binding protein 1 modulates Rev-dependent human immunodeficiency virus type 1 RNA expression. Zhou Y., Rong L., Zhang J., Aloysius C., Pan Q., Liang C. Virology 393:210-220(2009) · Mapped (2) |
| The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. Rong L., Zhang J., Lu J., Pan Q., Lorgeoux R.P., Aloysius C., Guo F., Liu S.L., Wainberg M.A., Liang C. J. Virol. 83:7536-7546(2009) · Mapped (3) |
| Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Wang J.H., Zheng X., Ke X., Dorak M.T., Shen J., Boodram B., O'Gorman M., Beaman K., Cotler S.J., Hershow R. et al. Virol. J. 6:46-46(2009) · Mapped (1,696) |
| Fragile X mental retardation protein restricts replication of human immunodeficiency virus type 1. Pan Q., Rong L., Zhao X., Liang C. Virology 387:127-135(2009) · Mapped (6) |
| Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry. Rothwangl K.B., Rong L. Virol. J. 6:12-12(2009) · Mapped (144) |
| Role of the HIV gp120 conserved domain 1 in processing and viral entry. Wang J., Sen J., Rong L., Caffrey M. J. Biol. Chem. 283:32644-32649(2008) · Mapped (5) |
| Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs. Rong L., Livingstone M., Sukarieh R., Petroulakis E., Gingras A.C., Crosby K., Smith B., Polakiewicz R.D., Pelletier J., Ferraiuolo M.A. et al. RNA 14:1318-1327(2008) · Mapped (6) |
| Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly. Zhou Y., Rong L., Lu J., Pan Q., Liang C. |
| Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Rothwangl K.B., Manicassamy B., Uprichard S.L., Rong L. Virol. J. 5:46-46(2008) · Mapped (146) |
| The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Ma J., Rong L., Zhou Y., Roy B.B., Lu J., Abrahamyan L., Mouland A.J., Pan Q., Liang C. Virology 375:253-264(2008) · Mapped (10) |
| Translational control of the innate immune response through IRF-7. Colina R., Costa-Mattioli M., Dowling R.J., Jaramillo M., Tai L.H., Breitbach C.J., Martineau Y., Larsson O., Rong L., Svitkin Y.V. et al. Nature 452:323-328(2008) · Mapped (8) |
| Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Toth C., Rong L.L., Yang C., Martinez J., Song F., Ramji N., Brussee V., Liu W., Durand J., Nguyen M.D. et al. Diabetes 57:1002-1017(2008) · Mapped (1) |
| The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Zhou Y., Ma J., Bushan Roy B., Wu J.Y., Pan Q., Rong L., Liang C. Virology 372:97-106(2008) · Mapped (1) |
| An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody. Shen J., Vil M.D., Zhang H., Tonra J.R., Rong L.L., Damoci C., Prewett M., Deevi D.S., Kearney J., Surguladze D. et al. Biochem. Biophys. Res. Commun. 357:1142-1147(2007) · Mapped (10) |
| The RAGE axis in early diabetic retinopathy. Barile G.R., Pachydaki S.I., Tari S.R., Lee S.E., Donmoyer C.M., Ma W., Rong L.L., Buciarelli L.G., Wendt T., Horig H. et al. Invest. Ophthalmol. Vis. Sci. 46:2916-2924(2005) · Mapped (11) |
| Comparative and functional genomic analyses of the pathogenicity of phytopathogen Xanthomonas campestris pv. campestris. Qian W., Jia Y., Ren S.-X., He Y.-Q., Feng J.-X., Lu L.-F., Sun Q., Ying G., Tang D.-J., Tang H. et al. Genome Res. 15:757-767(2005) · UniProtKB (4,239) |
| Characterization of murine leukemia virus recombinants that express H5N1 subtype avian influenza virus hemagglutinin glycoproteins. Liu H.L., Rong L.J., Zhou B., Wei J.C., Zheng Q.S., Chen P.Y. Sheng Wu Gong Cheng Xue Bao 21:47-51(2005) · UniProtKB (1) |
| RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. Cataldegirmen G., Zeng S., Feirt N., Ippagunta N., Dun H., Qu W., Lu Y., Rong L.L., Hofmann M.A., Kislinger T. et al. J. Exp. Med. 201:473-484(2005) · Mapped (3) |
| RAGE axis: Animal models and novel insights into the vascular complications of diabetes. Naka Y., Bucciarelli L.G., Wendt T., Lee L.K., Rong L.L., Ramasamy R., Yan S.F., Schmidt A.M. Arterioscler. Thromb. Vasc. Biol. 24:1342-1349(2004) · Mapped (33) |
| Increased adherence to Caco-2 cells caused by disruption of the yhiE and yhiF genes in enterohemorrhagic Escherichia coli O157:H7. Tatsuno I., Nagano K., Taguchi K., Rong L., Mori H., Sasakawa C. Infect. Immun. 71:2598-2606(2003) · UniProtKB (2) |
| Central role of RAGE-dependent neointimal expansion in arterial restenosis. Sakaguchi T., Yan S.F., Yan S.D., Belov D., Rong L.L., Sousa M., Andrassy M., Marso S.P., Duda S., Arnold B. et al. J. Clin. Invest. 111:959-972(2003) · Mapped (1) |
| RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Wendt T.M., Tanji N., Guo J., Kislinger T.R., Qu W., Lu Y., Bucciarelli L.G., Rong L.L., Moser B., Markowitz G.S. et al. Am. J. Pathol. 162:1123-1137(2003) · Mapped (6) |
| Solution structure of the viral receptor domain of Tva and its implications in viral entry. Wang Q.-Y., Huang W., Dolmer K., Gettins P.G., Rong L. J. Virol. 76:2848-2856(2002) · UniProtKB (1) |
| Purification and characterization of the SRS2 DNA helicase of the yeast Saccharomyces cerevisiae. Rong L., Klein H.L. J. Biol. Chem. 268:1252-1259(1993) · UniProtKB (1) |
